Yang Min, Fu Yaqian, Jiang Chengxue, Chen Jindong, Liu Minghui, Liu Jieyu
Department of Psychiatry, National Clinical Research Center for Mental Disorders, and National Center for Mental Disorders, The Second Xiangya Hospital of Central South University, No.139 Renmin Middle Road, Furong District, Changsha, 410011, Hunan, China.
Department of Ultrasound Diagnosis, The Second Xiangya Hospital of Central South University, Changsha, 410011, Hunan, China.
Sci Rep. 2025 Jul 24;15(1):26962. doi: 10.1038/s41598-025-11460-6.
This study aimed to explore the relationship between Bipolar Disorder (BD) and endocrine hormones, as well as the relationship between psychotropics and endocrine hormones. We recruited 55 drug-naïve women patients with BD, 66 long-term medicated women patients with BD, and 53 healthy controls. Serum levels of thyroid hormones, reproductive hormones, and insulin were measured in all participants. Clinical symptoms of depression and mania were measured in all patients with BD. After controlling for confounding factors, drug-naïve patients showed higher levels of free triiodothyronine (FT3), FT3/free thyroxine (FT4), and luteinizing hormone (LH) than controls, and medicated patients showed higher levels of FT3/FT4, thyroid stimulating hormone (TSH), anti-müllerian hormone (AMH), and insulin than drug-naïve patients. In addition, medicated patients showed a higher prevalence of subclinical hypothyroidism (24.24%) than drug-naïve patients (1.82%). In General Linear Model (GLM) analysis, use of lithium was associated with TSH levels (β = 0.22, p = 0.034), and use of antipsychotics was associated with AMH (β = 0.38, p = 0.005) and insulin levels (β = 0.27, p = 0.039). BD itself and its medication treatment are associated with alterations of thyroid and reproductive hormones, suggesting BD may interfere with hormone homeostasis through neuroendocrine mechanisms. Lithium, valproate, and antipsychotics should be prescribed carefully in BD patients with pre-existing hormone abnormalities.
本研究旨在探讨双相情感障碍(BD)与内分泌激素之间的关系,以及精神药物与内分泌激素之间的关系。我们招募了55名未服用过药物的BD女性患者、66名长期接受药物治疗的BD女性患者以及53名健康对照者。测量了所有参与者的血清甲状腺激素、生殖激素和胰岛素水平。对所有BD患者测量了抑郁和躁狂的临床症状。在控制混杂因素后,未服用过药物的患者游离三碘甲状腺原氨酸(FT3)、FT3/游离甲状腺素(FT4)和促黄体生成素(LH)水平高于对照组,接受药物治疗的患者FT3/FT4、促甲状腺激素(TSH)、抗苗勒管激素(AMH)和胰岛素水平高于未服用过药物的患者。此外,接受药物治疗的患者亚临床甲状腺功能减退的患病率(24.24%)高于未服用过药物的患者(1.82%)。在一般线性模型(GLM)分析中,使用锂与TSH水平相关(β = 0.22,p = 0.034),使用抗精神病药物与AMH(β = 0.38,p = 0.005)和胰岛素水平相关(β = 0.27,p = 0.039)。BD本身及其药物治疗与甲状腺和生殖激素的改变有关,提示BD可能通过神经内分泌机制干扰激素稳态。对于已有激素异常的BD患者,应谨慎开具锂盐、丙戊酸盐和抗精神病药物。